MOSKAL JOSEPH R. 4
4 · Aptinyx Inc. · Filed Jun 26, 2018
Insider Transaction Report
Form 4
Aptinyx Inc.APTX
MOSKAL JOSEPH R.
Chief Scientific Officer
Transactions
- Conversion
Common Stock
2018-06-25+9,673→ 368,736 total - Conversion
Series A-2 Convertible Preferred Stock
2018-06-25−266,851→ 0 total→ Common Stock (9,673 underlying) - Conversion
Common Stock
2018-06-25+8,464→ 359,063 total - Purchase
Common Stock
2018-06-25$16.00/sh+3,000$48,000→ 378,288 total - Conversion
Series A-1 Convertible Preferred Stock
2018-06-25−233,496→ 0 total→ Common Stock (8,464 underlying) - Conversion
Series B Convertible Preferred Stock
2018-06-25−180,734→ 0 total→ Common Stock (6,552 underlying) - Conversion
Common Stock
2018-06-25+6,552→ 375,288 total
Footnotes (2)
- [F1]Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.
- [F2]On June 25, 2018, the Reporting Person purchased 3,000 shares of common stock of the Issuer at a price of $16.00 per share pursuant to an underwritten public offering.